Correlation Between Vascular Biogenics and Novartis

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Vascular Biogenics and Novartis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vascular Biogenics and Novartis into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vascular Biogenics and Novartis AG ADR, you can compare the effects of market volatilities on Vascular Biogenics and Novartis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vascular Biogenics with a short position of Novartis. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vascular Biogenics and Novartis.

Diversification Opportunities for Vascular Biogenics and Novartis

0.55
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Vascular and Novartis is 0.55. Overlapping area represents the amount of risk that can be diversified away by holding Vascular Biogenics and Novartis AG ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Novartis AG ADR and Vascular Biogenics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vascular Biogenics are associated (or correlated) with Novartis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Novartis AG ADR has no effect on the direction of Vascular Biogenics i.e., Vascular Biogenics and Novartis go up and down completely randomly.

Pair Corralation between Vascular Biogenics and Novartis

Given the investment horizon of 90 days Vascular Biogenics is expected to under-perform the Novartis. In addition to that, Vascular Biogenics is 6.42 times more volatile than Novartis AG ADR. It trades about -0.03 of its total potential returns per unit of risk. Novartis AG ADR is currently generating about 0.04 per unit of volatility. If you would invest  7,691  in Novartis AG ADR on January 24, 2024 and sell it today you would earn a total of  1,821  from holding Novartis AG ADR or generate 23.68% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy74.09%
ValuesDaily Returns

Vascular Biogenics  vs.  Novartis AG ADR

 Performance 
       Timeline  
Vascular Biogenics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Vascular Biogenics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable essential indicators, Vascular Biogenics is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.
Novartis AG ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Novartis AG ADR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unsteady performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Vascular Biogenics and Novartis Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Vascular Biogenics and Novartis

The main advantage of trading using opposite Vascular Biogenics and Novartis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vascular Biogenics position performs unexpectedly, Novartis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novartis will offset losses from the drop in Novartis' long position.
The idea behind Vascular Biogenics and Novartis AG ADR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Other Complementary Tools

Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Transaction History
View history of all your transactions and understand their impact on performance
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins